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Abstract
Increased vascular permeability without morphological damage to the capillary
endothelium is the cardinal feature of dengue haemorrhagic fever (DHF)/dengue
shock syndrome (DSS). Extensive plasma leakage in various tissue spaces and
serous cavities of the body, including the pleural, pericardial and peritoneal cavities
in patients with DHF, may result in profound shock. Among various mechanisms
that have been considered include immune complex disease, T-cell-mediated,
antibodies cross-reacting with vascular endothelium, enhancing antibodies, com-
plement and its products, various soluble mediators including cytokines, selection
of virulent strains and virus virulence, but the most favoured are enhancing
antibodies and memory T cells in a secondary infection resulting in cytokine
tsunami. Whatever the mechanism, it ultimately targets vascular endothelium
(making it a battlefield) leading to severe dengue disease. Extensive recent work has
been done in vitro on endothelial cell monolayer models to understand the
pathophysiology of vascular endothelium during dengue virus (DV) infection that
may be translated to help understand the pathogenesis of DHF/DSS. The present
review provides a broad overview of the effects of DV infection and the associated
host responses contributing towards alterations in vascular endothelial cell
physiology and damage that may be responsible for the DHF/DSS.
Introduction
Dengue is a mosquito-borne Flavivirus of global public health
importance; an estimated 2.5 billion people in more than 100
countries are at risk of acquiring dengue viral infection with
more than 50million new infections being projected annually
(Halstead, 2007). The economic importance of dengue in the
developing world is also a major concern (Clark et al., 2005).
Dengue virus (DV) has four serotypes (1–4) and the virion
has 10 proteins, the core (C) andmembrane (M) proteins, the
envelope (E) glycoprotein, and seven nonstructural (NS)
proteins. Anti-E antibodies neutralize DV infectivity in vitro
and protect mice from DV challenge on passive transfer and
show a variable degree of cross-reactivity among the DV
serotypes and mediate antibody-dependent enhancement of
infection at nonneutralizing levels. Antibodies against NS1
can trigger complement-mediated lysis of DV-infected cells in
vitro and protect mice from DV challenge. At the same time,
these antibodies may cross-react with endothelial cells, lead-
ing to their activation and expression of cytokine, chemokine
and adhesion molecules, resulting in cell damage. NS3
protein is the main antigen that stimulates DV-reactive
CD41 and CD81 T-cell cells, which produce high levels of
IFN-g as well as tumour necrosis factor (TNF)-a, TNF-b and
chemokines including macrophage inhibitory protein-1b
upon interaction with DV-infected antigen-presenting cells,
and are efficient at lysis of DV-infected cells in vitro (reviewed
by Chaturvedi et al., 2006b). The virus infection can result in
a broad spectrum of clinical illness ranging from a mild
disease, dengue fever (DF), to a serious life-threatening
dengue haemorrhagic fever/dengue shock syndrome (DHF/
DSS) in a subset of patients. The characteristic features of
DHF are increased capillary permeability without morpholo-
gical damage to the capillary endothelium, thrombocytope-
nia, altered number and functions of leucocytes, altered
haemostasis and liver damage. Sudden and extensive plasma
leakage in tissue spaces and various serous cavities of the body
including the pleura, pericardium and peritoneal cavities and
associated haemorrhages, in patients with DHF grades III and
IVmay result in profound shock – DSS (Table 1) – that can be
fatal if not clinically managed in time (Halstead, 2002a, 2007;
Chaturvedi & Shrivastava, 2004).
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The pathogenesis of DHF is not fully understood despite
extensive work carried out in the last several decades, due
mainly to absence of an appropriate animal model. Various
mechanisms that have been suggested include enhancing
antibodies in secondary dengue, memory T-cell-mediated
pathogenesis, immune complex disease, complement and its
products, anti-NS1 antibodies that cross-react with vascular
endothelium, cytokine tsunami and other soluble mediators
such as high concentrations of soluble IL-2 receptor, soluble
CD4, soluble CD8, TNF receptors, IL-10 and macrophage
migration inhibition factor, together with possible selection
of virulent virus strains (South East Asian type DV-2) and
host genetic polymorphism (Table 2). Monocyte chemoat-
tractant CC chemokine ligand 2 (CCL2) and monocyte
chemoattractant protein-1 (MCP-1) are proteins that re-
duce tight junctions of vascular endothelium cells. High
concentrations of these proteins have been reported in
patients with DHF/DSS (Lee et al., 2006). Whatever the
mechanism, it ultimately targets endothelium (using it as a
battlefield) to produce pathological lesions and severe
dengue disease (Table 1). Extensive work has been done in
vitro to understand the pathophysiology of vascular en-
dothelium in various conditions using an endothelial cell
monolayer model. This has led to investigations on effects of
DV infection in vitro on vascular endothelium. The purpose
of this review is to provide a broad overview of the effects of
DV infection and host responses contributing towards
alterations in endothelial cell physiology.
Effects of DV infection on endothelial cells
in vivo
The clinical presentations of patients with DHF/DSS sum-
marized in Table 1 indicate that the severe dengue disease is
due to extensive involvement of endothelial cells over the
entire body. Studies on the pathogenesis of DHF/DSS are
greatly restricted because no animal model is available.
Although providing an inadequate model, mice have been
used since the studies of dengue virologist Professor Susumu
Hotta to answer some of the questions later validated in
human patients. This section summarizes findings on den-
gue patients and DV-infected mice (briefly), with an em-
phasis on direct or indirect effects on endothelium.
Infection of endothelial cells with DV in patients
with DHF and in mice
Electron microscopic studies of capillaries in skin biopsies
from patients with DHF show marked distortion, but
severely damaged vessels are not observed, and most of the
endothelial junctions are intact, although swelling of stray
endothelial cells is noted (Sahaphong et al., 1980). Histo-
pathological and ultrastructural changes in skin eruptions of
three DF patients showed swelling of the endothelial cells in
small vessels of the papillary dermis, diapedesis of neutro-
phils, extravasation of erythrocytes, perivascular mononuc-
lear cell infiltration, and degeneration of endothelial cells
and neutrophils (Yu et al., 1989). Jessie et al. (2004) studied
various tissues obtained from patients with DHF/DSS at
postmortem, from ante-mortem biopsies or from blood
clots to demonstrate DV infection using fluorescent anti-
body (FA), immunohistochemistry (IHC) and in situ hybri-
dization (ISH) and electron microscopic techniques. Viral
antigens were demonstrated in Kupffer and sinusoidal
endothelial cells of the liver; macrophages, multinucleated
cells and reactive lymphoid cells in the spleen; macrophages
and vascular endothelium in the lung; kidney tubules; and
monocytes and lymphocytes in blood-clot samples. Posi-
tive-strand viral RNAwas detected in the same IHC-positive
cells found in the spleen and blood-clot samples. The strong,
positive ISH signal in these cells indicated a high copy
number of viral RNA, suggesting replication. No morpho-
logical damage to endothelial cells has been reported,
although Limonta et al. (2007) have shown the presence of
apoptotic cells in pulmonary, intestinal, cerebral and white
blood cells in fatal cases of DHF/DSS from Cuba. In a mouse
model, intradermal inoculation of high titres of DV predis-
posed endothelial cells to TNF-a-induced cell death, leading
Table 1. Clinical effects of endothelial cell dysfunction during DV infection
Organ Effects on endothelium Clinical effect
Lung pleura Increased vascular permeability Pleural effusion
Lung alveoli Increased vascular permeability Haemoptysis
Pericardium Increased vascular permeability Pericardial effusion
Abdomen Increased vascular permeability Ascitis
Brain Damaged blood–brain barrier Encephalopathy
Gut Increased vascular permeability Haemoptysis, Malaena
Urinary tract Increased vascular permeability Haematuria
Female reproductive tract Increased vascular permeability Menorrhagia, bleeding per vaginum
The release of cytokines and other mediators released by activation of memory Tcells acts on endothelium, resulting mainly in opening up of junctions
between endothelial cells, thus increasing permeability.
FEMS Immunol Med Microbiol 53 (2008) 287–299c 2008 Federation of European Microbiological Societies
Published by Blackwell Publishing Ltd. All rights reserved
288 A. Basu & U.C. Chaturvedi
to endothelium damage and haemorrhage (Chen et al.,
2007). Cardier et al. (2006) examined levels of soluble
intercellular adhesion molecule and vascular cell adhesion
molecule (sICAM-1 and sVCAM-1), and the presence of
circulating endothelial cells (CECs), as evidence of vascular
damage, in peripheral blood from DHF patients. They
concluded that high levels of sICAM-1 and sVCAM-1,
together with the presence of CECs, provided further
evidence of endothelium damage and activation in DHF
patients
Cytokine Tsunami in patients with DHF
Severe dengue disease, DHF/DSS, is the result of a ‘cytokine
tsunami’ developing in the patients (Chaturvedi et al.,
2007). The data summarized in Table 3 show that several
cytokines are markedly increased in severe disease. The most
significant finding reported for the first time from patients
with DHF during a 1996 epidemic in India was the shift
from the predominant helper T-cell type 1 (Th1) response
observed in cases of DF to the Th2-type response in severe
cases of DHF grade IV, a finding later confirmed in a
number of studies (Chaturvedi et al., 1999a, 2000). IL-12
has a profound effect on the upregulation of Th1 cells while
its absence shifts the balance towards Th2-type cytokines.
Table 2. Various mechanisms proposed for immunopathogenesis of DHF
Group Mechanism Effects References
Antibody Enhancement of infection Increased cellular infection
and viral load
Halstead (1989, 2007)
Immune complex Complement activation Theofilopoulos et al. (1976),
Malasit (1987)
Cross-reactivity with endothelial cell
and coagulation proteins
Bleeding Chungue et al. (1994), Markoff et al.
(1991), Falconar (1997)
Cross-reactivity with endothelial cell
and NS1 protein
Apoptosis, inflammatory activation Lin et al. (2005)
T lymphocytes Suppressor T cells Prevention of DHF, increased
pathology
Chaturvedi et al. (2007)
Memory T cell Increased pathology Mongkolsapaya et al. (2006)
Shift from Th1 to Th2 Increased pathology Chaturvedi et al. (2000)
Cytokine Tsunami Increased capillary permeability Chaturvedi et al. (1999, 2000, 2007)
Bystander cell lysis Liver injury Gagnon et al. (1999)
Macrophage and dendritic
cells
Cytokine tsunami Increased capillary permeability Chaturvedi et al. (2006a)
Free radicals: NO, O2
–, etc. Increased capillary permeability Chaturvedi et al. (2006a)
Metalloprotein Increased capillary permeability Luplertlop et al. (2006)
Vascular endothelial cells
(mainly in vitro work)
eNOS, NO Increased capillary permeability Yuan (2006)
Endothelin etc. Increased capillary permeability Jiang et al. (1999)
IL-8, IL-6 Increased capillary permeability Avirutnan et al. (1998), Huang et al.
(2000)
Decreased soluble vascular
endothelial growth receptor 2
Increased capillary permeability Srikiatkhachorn et al. (2007)
Virus virulence Asian genotype Increased transmissibility and
cellular infection.
Leitmeyer et al. (1999), Rico-Hesse
(2003)
Selection of virulent strains in
humans and mosquitoes.
Cologna et al. (2005)
American genotype Do not produce DHF/DSS Watts et al. (1999)
Host genetics Polymorphism of genes Increased or decreased
predisposition for DHF
Chaturvedi et al. (2006b)
Mainly review papers, to save space.
Table 3. Cytokine levels in patients with dengue
Cytokines DF DHF
IL-1b No change No change
IL-2 Marked increase Increase
IL-4 Decrease Marked increase
IL-6 Increase Marked increase
IL-8 Marked increase Marked increase
IL-10 Decrease Marked increase
IL-12 Marked increase Decrease
IL-13 Decrease Marked increase
IL-18 Increase Marked increase
TNF-a Marked increase Marked increase
IFN-g Marked increase Increase
Transforming
growth factor-b
Decrease Marked increase
Cytotoxic factor Increase Marked increase
Modified from Chaturvedi et al. (2005).
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Elevated levels of IL-12 are seen in patients with milder
dengue illness (DF) and completely absent in patients with
DHF grades III and IV (Pacsa et al., 2000). Thus, IL-12 may
play a role in preventing severe dengue disease by maintain-
ing the Th1-type response. Increased levels of IL-8 in the
sera and IL-8 mRNA in peripheral-blood mononuclear cell
(PBMCs) are associated with increasing severity of DHF and
death of patients. It has been suggested that the presence
of high levels of IL-8 may be a useful indicator of serious
outcome for dengue illness (Raghupathy et al., 1998).
Furthermore, the severity of disease and the duration of
illness are correlated with levels of TGF-b1; maximum levels
of TGF-b1 are detected in patients with DHF grade IV
(Agarwal et al., 1999). Serum IL-6 concentrations are higher
in patients with DHF and DSS (Chaturvedi et al., 1999a;
Juffrie et al., 2000). Activated neutrophils release proteinases
such as elastase, which may facilitate neutrophil-mediated
endothelial injury, and activate the complement, coagula-
tion and fibrinolytic systems. As increased serum IL-8 and
elastase are found in patients with severe infections, they
may have an important role in the pathogenesis of dengue
infections (Raghupathy et al., 1998; Juffrie et al., 2000). The
severity of plasma leakage in DV-infected patients inversely
correlates with plasma levels of soluble vascular endothelial
growth factor A (VEGF-A) receptors (VEGFR2). Further-
more, plasma viral load correlates with the degree of decline
in plasma soluble VEGFR2 (Srikiatkhachorn et al., 2007).
These results suggest that VEGF regulates vascular perme-
ability and that binding to soluble VEGFR2 controls its
activity. DV-induced changes in surface and soluble
VEGFR2 expression may be an important mechanism of
plasma leakage in DHF.
Cytotoxic factor (CF) in patients with dengue
infection
A unique cytokine, CF, is produced by CD41 T cells during
DV infection of mice and humans. The amino-terminal
sequence of CF has no homology with any known proteins.
The majority of patients with dengue show the presence of
CF in their sera, with peak amounts in the most severe cases
of DHF grade IV (Chaturvedi et al., 1999b). CF selectively
kills CD41 T cells and H-2A macrophages (Mf) and
induces H-2A1 Mf to produce another cytokine, the Mf
cytotoxin (CF2) that amplifies the effect of CF (Fig. 1). CF
was detected in about 70% of the stored sera from patient
with dengue at AFRIMS, Bangkok (Mukerjee et al., 1997),
and later at Lucknow, India, during the first extensive
epidemic of DHF in India in 1996. In the majority of
patients with dengue, sera was positive for CF, with peak
levels in the most severe cases of DHF grade IV (Chaturvedi
et al., 1999b). CF was purified from the pooled sera of the
DHF patients. On intravenous inoculation into mice CF
increased capillary permeability and damaged the blood–
brain barrier, indicating the role of CF in pathogenicity
(Mukerjee et al., 1997). CF and CF2 may be pathogenesis-
related proteins, capable of reproducing DHF-like patholo-
gical lesions in mice (Fig. 1), such as increased capillary
permeability, cerebral oedema and blood leukocyte changes
(Chaturvedi et al., 1997). CF is produced in ex vivo cultures
of CD41 T cells obtained from peripheral blood of patients
with severe dengue disease (Agarwal et al., 1998). The
production of CF precedes the clinical illness in mice and
humans. The DHF-like pathological lesions produced by
CF/CF2 can be prevented by pretreatment of mice with anti-
CF antibodies. Furthermore, active immunization of mice
using CF as antigen protects them against subsequent
challenge with CF. Challenge of such mice with a lethal
intracerebral dose of DV results in death without the
appearance of clinical symptoms of the disease (Chaturvedi
et al., 1994). On the basis of data obtained from experi-
mental mice and patients, we proposed that DV replicates in
Mf and induces CD41 T cells to produce CF, which
stimulates Mf to produce CF2. CF/CF2 induce Mf to
produce free radicals, nitrite, reactive oxygen and peroxyni-
trite (Misra et al., 1998; Chaturvedi et al., 2000, 2006a). The
free radicals, besides killing the target cells via apoptosis,
also directly upregulate production of proinflammatory
cytokines IL-1b, TNF-a, IL-8 and hydrogen peroxide in
Mf. The change in relative levels of IL-12 and TGF-b shifts a
Th1-dominant response to a Th2-biased response, resulting
in an exacerbation of dengue disease. Vascular permeability
is increased due to the combined effect of a cytokine
tsunami, release of histamine, free radicals, the products of
the complement pathway, etc. Thus, the key player appears
to be CF/CF2, but their activity is regulated by CF-auto-
antibodies generated (Fig. 1) in patients with dengue disease
(Chaturvedi et al., 2001).
DV C
CF M
CF2 NO+O =
Peroxynitrite
Apoptosis
(mast cell /
endothelial cell etc) 
Histamine
cytokines etc
Increased
permeability
DC
T CD4+
M M
−
M
Anti-CF-Abs
Fig. 1. Schematic presentation of CF cascade leading to increased
vascular permeability.
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Role of T lymphocytes in patients with DHF
In an excellent review, Stephenson (2005) discussed the role
of T cells in DHF. DHF occurs more frequently in patients
with secondary infection with a heterologous DV serotype.
This is due to increased uptake by macrophages of the DV-
enhancing antibody complex, resulting in increased replica-
tion. The presentation of viral peptides complexed with
human leucocyte antigen (HLA) molecules to memory
T cells leads to proliferation and the production of proin-
flammatory cytokines that can directly affect vascular en-
dothelial cells, resulting in plasma leakage. The rapid
induction of cross-reactive memory T cells (mainly NS3-
specific) during a secondary infection would be consistent
with the increased incidence of DHF and DSS. A DV-specific
memory lymphocyte response has been detected even 20
years following a primary DV infection (Sierra et al., 2002).
The cascade of memory T-cell activation and a ‘tsunami’ of
inflammatory cytokines and other chemical mediators re-
leased mainly from T cells, monocytes/macrophages and
endothelial cells ultimately cause an increase in vascular
permeability. The interplay of different inflammatory cyto-
kines induced during DV infection plays a role in either
protection or increased disease severity (Chaturvedi et al.,
2000). Suppressor T cells were demonstrated in DV-infected
mice that were considered to protect against development of
DHF by suppressing enhancing antibody production (Cha-
turvedi et al., 1984) but could increase severity by producing
IL-10/TGF-b (Chaturvedi et al., 2007). This remains to be
investigated in human patients. A shift of the Th1 response
to Th2 response in patients with DF results in a severe
dengue disease, DHF/DSS (Chaturvedi et al., 1999a). Mon-
gkolsapaya et al. (2003) have reported that during acute
infection in children, few dengue-responsive CD81 T cells
are recovered which show an activated phenotype and are
undergoing apoptosis. These DV-specific T cells have low
affinity for the infecting virus and higher affinity for
previously encountered strains. Cross-reactive DV-specific
T cells show high cytokine production, which may contri-
bute to vascular leakage (Mongkolsapaya et al., 2006).
Mangada & Rothman (2005) have shown that TNF-a-/
IFN-g-positive CD41 T-cell ratios varies between peptides,
but the ratio of the sum of responses was highest against
heterologous serotypes. These results demonstrate epitope
sequence-specific differences in T-cell effector function that
may play a role in the immunopathogenesis of DHF.
Profound T-cell activation and death may contribute to the
systemic disturbances leading to DHF, and original anti-
genic sin in the T-cell responses may suppress or delay viral
elimination, leading to higher viral loads and increased
immunopathology. Appanna et al. (2007) investigated DV-
specific T-cell responses to 32 peptide antigens from the
structural and nonstructural regions from a DV isolate and
found that predominantly NS3 422-431 are important T-cell
targets. The findings also reveal high frequencies of T cells
that recognize both serotype-specific and cross-reactive
antigens in patients with DHF. Immunizing mice with
different sequences of DV serotypes and measuring the
frequency of peptide-specific T cells after infection have
supported this view. On adoptive transfer the memory T
cells respond preferentially to the secondary infection,
indicating that cross-reactive T cells from a primary infec-
tion alter the immune response during a heterologous
secondary infection (Beaumier et al., 2008).
Pathogenesis of DHF in infants
Age is an important variable in the outcome of secondary
DV-2 infections. DHF/DSS fatality and hospitalization rates
are highest in young infants and the elderly. The risk that a
child will die during a secondary DV-2 infection is nearly
15-fold higher than that in adults (Guzma´n et al., 2002).
Acute illness blood samples from infants with DHF/DSS
show overproduction of both proinflammatory and anti-
inflammatory cytokines (Nguyen et al., 2004). Evidence
suggests that enhancing and cross-reactive neutralizing
antibodies regulate dengue epidemics and disease severity.
DHF/DSS in infants under 1 year of age have been reported
from different countries. Curiously, all the infants had
primary DV infection. Limited work has been done to
explain this phenomenon in infants as DHF/DSS occurs
mostly following secondary dengue infections. Classic DHF/
DSS arises during initial dengue infections in infants with
low circulating amounts of maternal dengue antibodies, an
observation that precludes an exclusive causal role for
secondary T-cell responses (Halstead, 2007). PBMC apop-
tosis and plasma soluble levels of CD95, a mediator of
apoptosis, were determined in sequential samples from
children participating in a prospective study of DV infec-
tions by Myint et al. (2006). The level of PBMC apoptosis
correlated with dengue disease severity. Apoptosis appears
to be involved in modulation of the innate and adaptive
immune responses to DV infection. Halstead et al. (2002b)
have explained this phenomenon by comparison with a
coronavirus, the feline infectious peritonitis virus (FIPV)
infection in cats. Like the feline coronaviruses, DV also
circulates as two biotypes: DV-2 American genotype does
not cause DHF/DSS, while DV-2 SE Asian genotype does
(Watts et al., 1999). Like feline coronaviruses, the severity of
disease with the two DV biotypes may be regulated by cross-
reactive antibodies (Kochel et al., 2002). More work on
viral–antibody interactions at the structural level is needed
to clarify early pathogenesis events in DHF/DSS in infants.
In an excellent review, Halstead (2007) discussed in detail
the differences between DHF in adults and that in infants
and the pathogenesis in the two groups of patients.
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Effects of DV infection on endothelial cells
in vitro
Endothelial cell monolayers have been used widely to study
the pathophysiological changes that occur during DV infec-
tion to answer questions raised in patients with DHF/DSS.
Most of the mechanistic information has come from in vitro
experiments and remains to be translated to human pa-
tients. However, these in vitro experiments have generated
useful knowledge about the mechanisms that may be
occurring intracellularly. In this section, the relevant find-
ings of such experiments performed on DV-infected en-
dothelial monolayers are described, with emphasis on the
direct or indirect effects on endothelium.
Vascular endothelium
The vascular endothelial cells lining the inner lumen of
blood vessels and capillaries constitute the primary anato-
mical blood–tissue barrier. The vascular endothelial cells are
highly organized, physiologically specialized and form the
major gatekeepers that control tissue nutrient flux, micro-
circulatory dynamics and permeability of macromolecules.
Their role in immune functions and haemostasis is of equal
importance. However, the integrity of the barrier and
endothelial cell functions in the microcirculatory beds is
not constant but is physiologically regulated by many factors
such as electrolyte balance, metabolic status of the tissue,
hormones, and neurotransmitters, and most importantly
the pathophysiology of vascular disorders (Cines et al.,
1998). Endothelial cells can dramatically alter their perme-
ability in response to immune responses, especially to
cytokines such TNF-a, IFN-g, IL-6, IL-8 and other proin-
flammatory cytokines (Crone, 1986). Confluent monolayers
of the human dermal microvascular endothelial cell line
HMEC-1 etc. are utilized as an experimental model to study
the cellular responses induced by DV. Infected monolayers
show increased permeability without evident cytopathic
effects on the monolayer. The ontogeny of the vascular
endothelial cells occurs from the blood islands of the
primitive yolk sac (Risau & Flamme, 1995) and later as
angioblasts from the cardiac crescent of the mesodermal
plates. Further development, differentiation and tissue-
specific reorganization of these cells occur into organ-
specific vascular beds through complicated developmental
pathways that include growth factors such as VEGF, factors
like tie-1, endothelins and vascular active peptides that
interact through complex molecular signalling pathways
(reviewed by Cines et al., 1998) leading to the final organiza-
tion of the vascular tree. Recent studies have used transgenic
mouse models and an in vitro model of embryonic stem cell
differentiation, which have contributed to the current
understanding of the cellular and molecular pathways
regulating hemangioblast development and differentiation.
Haematopoietic and endothelial cells develop from meso-
derm via a transitional progenitor known as the hemangio-
blast. Flk-1, a receptor tyrosine kinase, and Scl, a basic
helix–loop–helix transcription factor, are two critical mole-
cules functioning in this process. Recent studies have shown
that Flk-1-expressing mesoderm contributes to the circula-
tory system, including haematopoietic, endothelial, smooth
muscle, skeletal muscle and cardiac muscle cells. Further-
more, hemangioblast specification within Flk-1-expressing
mesoderm is regulated by Scl expression (Lugus et al., 2005;
Yao et al., 2007). The endothelial progenitor cells (EPCs)
found in the bone marrow and peripheral blood are
incorporated into injured vessels and become mature en-
dothelial cells during re-endothelialization and neovascular-
ization processes. These cells express several surface markers,
including CD34 and CD133 antigens, and may promote
local angiogenesis by secreting angiogenic growth factors in
a paracrine manner (Miller-Kasprzak & Jagodzin˜ski, 2007).
In vitro alterations in endothelial cell biology by
dengue viruses
Endothelial cells are permissive to DV infection in vitro. A
significant amount of research has been carried out on pure
endothelial cell cultures to study pathophysiology during
DV infection in vitro. Infection of endothelial cells by DV
has been studied but has resulted in conflicting findings; the
role of endothelial cells in dengue disease pathogenesis
remains incompletely understood. Vascular endothelial cell
dysfunction may be caused by various stimuli, including
infectious pathogens, cytotoxic reagents and pathophysiolo-
gical mechanisms mediated by immune responses.
Replication of DV in endothelial cells from human
umbilical cord vein (HUVEC) was demonstrated by virus
titres and immunofluorescent antibody studies (Bunyaratvej
et al., 1997). Replication of DV in HUVEC is inhibited by
ribavirin, an antiviral synthetic guanosine analogue (Huang
et al., 2000). Talavera et al. (2004) reported that 40 % of the
HMEC-1 cells expressed DV proteins. Several studies have
shown susceptibility of endothelial cells to DV infection with
induction of cytokine production, apoptosis of target cells
and altered transcriptional factor activity (Avirutnan et al.,
1998). The effects of DV infection on gene expression in
HUVECs have been studied by Warke et al. (2003) using
microarray and differential display analysis. They have
showed evidence of upregulation of 269 genes that broadly
included cellular defence pathway, immune and inflamma-
tory response genes while a downregulated cluster of 169
genes mostly included cytoskeletal and membrane-
associated genes. Furthermore, recombinant TNF-related
apoptosis-inducing ligand (rTRAIL) inhibited DV titres
in DV-infected dendritic cells (DCs) by an apoptosis-
independent mechanism (Warke et al. (2008). These data
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suggest that TRAIL plays an important role in the antiviral
response to DV infection and may be a candidate for
antiviral interventions against DV. The data from this study
also showed significant activation of the myxovirus pathway
(MxA), which has been characterized as a cellular antiviral
response. In addition, other genes such as PLSCR1 asso-
ciated with phosphotidylserine metabolism in cells are also
affected, suggesting possible interference in basic signal-
transduction pathways by DV infection (Wiedmer et al.,
2000). Kinglsey et al. (2006), using high density arrays,
showed a more heterogeneous and differential gene expres-
sion in endothelial cell line ECV304 in response to DV
infection that involved downregulation of apoptotic path-
ways. However, more consistent and possible physiologically
relevant data come from recent studies that have shown
significant alterations in the gene expression of haemostati-
cally important molecules such as thrombomodulin, tissue
plasminogen activator (tPA) and tissue factor inhibitor in
DV-infected endothelium (Jiang et al., 2007). Alterations in
the b-integrin expression after DV infection of HMEC-1
might provide clues towards understanding the origin of the
capillary barrier ‘breach’ that results in leakage given that
integrands are crucial for cellular adherence (Zhang et al.,
2007). DV infection induces the production of tPA but not
of plasminogen activator inhibitor 1 in human endothelial
cells, which is regulated by IL-6 (Huang et al., 2003).
Activation and damage of HMEC could be induced in vitro
by inflammatory mediators present in the sera of dengue
patients, as indicated by an increase in ICAM-1 expression
(Cardier et al., 2005). Recombinant DV envelope glycopro-
tein binds to three proteins on the surface of ECV304 cells.
This virus–cell interaction may be associated with the
receptor complex specific for DV infection of endothelial
cells (Wei et al., 2003). Dewi et al. (2008) have analysed the
interaction among PBMCs, DV and HUVEC in vitro by
studying transendothelial electrical resistance (TEER) and
transalbumin permeability. The results indicate that PBMCs
increased the permeability of DV-2-infected HUVECs and
that the increased permeability was concomitant with
morphological change and a decrease in VE-cadherin ex-
pression. The results suggest that functional impairment of
the DV-2-infected HUVEC monolayer was caused by inter-
action with PBMCs.
Endothelial cell activation and production of IL-8
during DV infection
Anderson et al. (1997) reported that HUVECs are activated
when exposed to culture fluids (containing TNF-a) from
DV-infected PBMCs. Activation is strongest for endothelial
cell expression of VCAM-1 and ICAM-1. In contrast,
activation of endothelial cell E-selectin expression appears
to be more transient. Endothelial cells inoculated directly
with DVor with anti-DV antibody combinations are poorly
infectable. Among the proinflammatory cytokines and their
mRNAs measured (IL-6, IL-1b, IL-8, TNF-a), in the culture
supernatant of DV-infected primary human monocytes, IL-
8 shows the greatest change. Similarly, two cell lines, 293T (a
human epithelial cell line) and ECV304 (an endothelial cell
line), respond to DV infection by increasing IL-8 synthesis.
IL-8 produced by infected monocytes, endothelial or other
epithelial cells is associated with the hyperacetylation of
histones bound to the IL-8 promoter in addition to the
activation of transcription by NF-kB (Bosch et al., 2002).
Infection of human endothelial cells with DV induces the
transcriptional upregulation and secretion of RANTES and
IL-8 and apoptosis of cells (Avirutnan et al., 1998). DV
infection of HepG2 and primary DCs induces the produc-
tion of IL-8, RANTES, MIP-1a and MIP-1b, whereas only
IL-8 and RANTES are induced in HEK293 cells. Transfec-
tion of a plasmid expressing NS5 or a DV replicon induces
IL-8 gene expression and secretion while RANTES expres-
sion is not induced. Furthermore, IL-8 induction by NS5 is
principally through CAAT/enhancer binding protein,
whereas DV infection also induces NF-kB (Medin et al.,
2005). Treatment with anti-inflammatory drugs has variable
effects on IL-8 secretion in different cell types during DV
infection (Medin & Rothman, 2006). The findings of
Talavera et al. (2004) on confluent monolayers of the human
dermal microvascular endothelial cell line HMEC-1 suggest
that IL-8 production by DV-infected monolayers contri-
butes to the virus-induced effect on the cytoskeleton and
tight junctions and thereby modifies transendothelial per-
meability. In vitro studies show that mouse primary micro-
vascular endothelial cells are susceptible to DV but that
TNF-a enhances DV-induced apoptosis.
Effects of DV infection on tight junction
complex of endothelium
The physiological basis of endothelial integrity lies in the
presence of intercellular junctions known as tight junctions
complexes (TJCs) that allow vectorial transport of solutes
and other biological macromolecules (Blum et al., 1997).
The TJCs also regulate the overall permeability of endothe-
lial barrier functions. The cellular basis of this has been
studied extensively and has been attributed to dynamic
rearrangements of the cytoskeleton and its association with
TJCs primarily through actin. Alterations in the sealing
capacity of the junctions through modifications of the TJ
can lead to enhanced permeability (Cereijido et al., 1989).
Although the detailed molecular biology of the TJ is beyond
the scope of this review, the most important molecules that
make the TJ relevant to vascular pathophysiology include
the zonula proteins (ZO 1-3), occludins and claudins
(Bazzoni & Dijana, 2004). All three protein families are
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integral to normal functioning of the TJC in maintaining
endothelial permeability. They function at different levels
from being purely structural scaffolds to interacting with
complex signalling pathways within the cell, such as the ZO
proteins that are members of membrane-associated guanyl
kinase family (MUGK). Increased production of IL-8 occurs
in DV-infected primary human monocytes and in human
epithelial and endothelial cell lines (Bosch et al., 2002). The
findings of Talavera et al. (2004) suggest that IL-8 produc-
tion by infected monolayers contributes to the virus-
induced effect on the cytoskeleton and TJs and thereby
modifies transendothelial permeability. Lee et al. (2006)
reported that MCP-1 expression is induced in DV2-infected
monocytes and lymphocytes, but not in liver or endothelial
cells. Exposing monolayers of HUVECs to recombinant
human MCP-1 (rhMCP-1) or to the culture supernatant of
DV2-infected human monocytes increased the vascular
permeability of the cells. This was due to disrupted TJ
protein ZO-1 of HUVECs that was partially mediated by
MCP-1. Recently, Meertens et al. (2008) have reported that
the TJ proteins claudins-1, -6 and -9 function equally well as
entry cofactors in endothelial cells for hepatitis C virus,
another member of Flaviviridae.
Dengue viruses and changes in endothelium
permeability
Dewi et al. (2004) studied the effect of proinflammatory
cytokines and DV on the transendothelial electrical resis-
tance and permeability alterations. They revealed suscept-
ibility of endothelial cells to DV and also significant
increases in permeability and electrical resistance of the cells
after exposure to TNF-a.
However, because the plasma leakage in DHF cases occurs
at the time of defervesence, it becomes important to
examine the profile of proinflammatory cytokines in a
time-course manner. Jose et al. (2005) showed differential
effects of the sera from DHF cases on the activation of
HMEC-1, according to the day of disease evolution. Sera
from the day of defervescence had the strongest activating
potential in relation to later stages of disease and correlated
with the risk for DHF. This study also showed the important
but not essential role of TNF-a in possibly affecting the
permeability of endothelial cells in DHF that was further
supported from a recent study using a mouse model of
dengue (Chen et al., 2007). Although DV can infect different
cell types, cells of the monocytic lineage such as Langerhans
cells and interstitial DCs are thought to be the primary
targets of DV. Immature monocyte-derived DCs are also
susceptible to DV with subsequent activation and release of
vasoactive cytokines such as IL-8 and TNF (Juffrie et al.,
2000). An injury causes transendothelial migration of the
DCs and expression of matrix metalloproteinases that can
have deleterious effects of endothelial cell integrity (Asahi
et al., 2001). In vitro, DV suppresses soluble VEGFR2
production by endothelial cells but upregulates surface
VEGFR2 expression and promotes response to VEGF sti-
mulation (Srikiatkhachorn et al., 2007). Luplertlop et al.
(2006) showed that DV-infected DCs overproduced soluble
gelatinolytic matrix metalloproteinase MM9 and MMP2
with loss of the platelet endothelial adhesion molecule
(PECAM) expression and increase in vascular permeability.
These studies have initiated the need to examine in more
detail the possible role of host factors in the origin of
dengue-associated vascular pathophysiology. Supernatants
from DV-infected monocyte-derived macrophages contain
factors that increase HUVEC permeability, but this is not
accompanied by endothelial cell infection or directly corre-
lated with release of DV or TNF-a from monocyte-derived
macrophages (Carr et al., 2003). It was found that the
increased permeability and disrupted TJs of HUVECs are
affected through a mechanism partially dependent on
MCP-1, which is secreted by DV-infected monocytes and
lymphocytes (Lee et al., 2006). DV-infected immature DCs
overproduce soluble gelatinolytic MMP-9 and to a lesser
extent MMP-2, which enhances endothelial permeability
(Fig. 2). This permeability was associated with a loss of
expression of PECAM-1 and vascular endothelium–cadher-
in cell adhesion molecules and redistribution of F-actin
fibres. These in vitro observations have been confirmed in
an in vivo vascular-leakage mouse model (Luplertlop et al.,
2006). Jiang et al. (2007) have shown that DV could
promote the expression of thrombomodulin in cultured
HUVEC, thus increasing anticoagulation, and enhance tPA
activity, increasing risk of haemorrhage. Zhang et al. (2007)
reported that DV infection induces upregulated expression
DV-infection
Decreased production Increased production
ET-1 Ani-NS1-ab     MMP-9  Cyokine
tsunamiPG12
NO, O−, Peroxynitrite
Increased permeability
CF/CF2
Fig. 2. Schematic representation of the possible interaction between
DVs, cytokines and host factors leading to endothelial cell pathology.
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of b3-integrin, which is required for DV entry into human
HMEC-1. Permeability alteration of microvascular endothe-
lium is a factor in the plasma leakage produced by DV
infection, and b3-integrin plays central roles in maintaining
capillary integrity and regulating vascular permeability.
Role of nitric oxide (NO) generated during DV
infection
NO, generated from L-arginine by NO synthase (NOS), is a
multifunctional molecule that is involved in cytotoxic as
well as cytoprotective processes. Its synthesis is highly
regulated by the cell because an alteration in NO production
is associated with a variety of pathological effects, such as
vasodilatation, inflammation, thrombosis, immune re-
sponse and neurotransmission. Generation of NO may
result in either initiation or suppression of apoptosis. The
involvement of NO in apoptosis induction has been re-
ported in different cell systems, although the mechanisms
are not fully understood. Rodriguez-Ortega (1998) dis-
cussed the evidence that links NO with the pathology of the
severe dengue disease. Macrophage lineage cells are profes-
sional NO producers. NO produced by them downregulates
replication of DV. CF/CF2 induces production of NO2
– in the
spleen cells in a Ca21-dependent manner, which may be a
mechanism of target cell killing (Mukerjee et al., 1996). CF2
also induces production of superoxide anion (O2
–) and
hydrogen peroxide (H2O2) by the spleen cells of mice
in vitro and in vivo and the killing (Fig. 2) may possibly be
by generation of peroxynitrite (Misra et al., 1996a, 1996b,
1998). Neves-Souza et al. (2005) reported that activation of
DV-infected monocytes is based on induction of iNOS both
in vivo and in vitro.
Role of cross-reacting anti-DV NS1 antibody
Lin et al. (2002) have demonstrated that antibodies against
DV NS1 generated in mice cross-react with human and
mouse vascular endothelium and platelets. After binding,
mouse anti-NS1 antibodies induce endothelial cell apoptosis
in a caspase-dependent manner. Inducible NOS expression
shows a time- and dose-dependent correlation with NO
production. Endothelial cell apoptosis, characterized by
exposure of phosphatidylserine on the cell surface and
nuclear DNA fragmentation, is blocked by treatment with
the NOS inhibitor No-nitro-L-arginine methyl ester. Further
studies have demonstrated that the expression of Bcl-2 and
Bcl-xL decreased in both mRNA and protein levels, whereas
p53 and Bax increased after anti-NS1 treatment. Cyto-
chrome c release is also observed. All of these effects could
be inhibited by No-nitro-L-arginine methyl ester. Taking
these data together, anti-NS1 antibodies act as autoantibo-
dies that cross-react with noninfected endothelial cells and
trigger the intracellular signalling leading to the production
of NO and to apoptosis (Lin et al., 2002, 2004). This has
been confirmed in patients with DHF/DSS where antibodies
against NS1 present in patient sera cross-react with en-
dothelial cells and induce apoptosis via a caspase-dependent
pathway and cause cell lysis in the presence of complement.
DHF/DSS patient sera show higher percentages of cytotoxi-
city than DF patient sera (Lin et al., 2003). Human platelets
adhere to DV-stimulated HUVEC and this interaction could
contribute to the thrombocytopenia observed during infec-
tion (Krishnamurti et al., 2002). Complement activation
was proposed to be responsible for DHF, but the cause of
complement activation was not known. Avirutnan et al.
(2006) have reported that complement activation mediated
by NS1 leads to local and systemic generation of anaphyla-
toxins and SC5b-9, which may contribute to the pathogen-
esis of the vascular leakage that occurs in patients with DHF/
DSS. Antibodies directed against DVNS1 has been shown to
cross-react with human platelets and endothelial cells lead-
ing to endothelial cell damage and inflammatory activation
(Lin et al., 2006).
Role of endothelin in endothelium permeability
Endothelial cells produce a number of factors that maintain
their physiological activity. The findings summarized in
Table 4 show that dysfunction of these factors during DV
infections increases permeability. Endothelin (ET-1) is pro-
duced by endothelial cells from a precursor, big-ET-1, by
endothelin-converting enzyme (ECE) found on the en-
dothelial cell membrane. Thrombin, cytokines, reactive
oxygen species, etc., stimulate the vascular endothelium to
produce and release of ET-1. Release of ET-1 is inhibited by
prostacyclin and nitric oxide. Binding of ET-1 to endothelial
ETb receptors stimulates the formation of NO. In the
Table 4. Effects of DV infection on vascular permeability through factors secreted by the endothelial cells
Factors secreted by endothelial cells Functions Effects of DV infection
Prostacyclin Vasodilation, inhibits platelet aggregation Inhibited
Nitric oxide Vasodilation, inhibits platelet adhesion and aggregation Increased
Endothelin-1 (ET-1) Vasoconstriction Inhibited
Tissue plasminogen activator (tPA) Regulates fibrinolysis Increased
Thrombomodulin Anticoagulant activity Increased
von Willebrand Factor Promotes platelet adhesion and activation of blood coagulation Increased
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absence of smooth muscle endothelin receptor stimulation,
this NO causes vasodilation (reviewed by Iglarz & Clozel,
2007). DV infection of HUVECs inhibits the production of
endothelin 1 (ET-1) and prostacyclin 2 (PGI2), thus affect-
ing their normal functions of secretion of vasoactive sub-
stances, resulting in increased vascular permeability (Fig. 3)
and impairment of homeostasis and blood coagulation
(Jiang et al., 1999).
Conclusions
Plasma leakage is a hallmark of DHF/DSS, characterized by a
sudden and transient localized plasma leakage resulting in
fluid accumulation in body cavities. Plasma leakage gener-
ally lasts no more than 48 h and is usually followed by rapid,
complete recovery. Presence of DV has been detected in
endothelial cells but it does not cause morphological da-
mage, and the vascular leakage is mediated indirectly by
various host factor cascades induced by the virus. Absence of
tissue inflammation suggests a transient change in factors
that regulate vascular permeability. In spite of a large
number of mechanisms proposed from time to time, as
discussed above, the precise mechanism of the pathogenesis
is not clearly understood. As the ultimate target is the
endothelial cells, a large body of data has accumulated from
the in vitro studies on pathophysiology of endothelial cell
monolayers during DV infection. As in mice, the endothelial
cell monolayers are not the true model of the human disease,
and only point to various possibilities that may operate in
vivo. Efforts have been made to develop animal models but
success has been limited. More intense studies are required
to translate the knowledge obtained from animal models
and in vitro experiments to human pathology.
Statement
U.C.C. has now retired.
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